In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call the CDC Reports Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques for other forms of information technology. Send comments to Anne O'Connor, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 30333. Written comments should be received within 60 days of this notice.
Proposed Project: Key Informant Interviews to Identify the Barriers to the Implementation of the New Targeted Testing and Treatment of Latent TB Infection Recommendations—NEW—In April 2000, the Centers for Disease Control and Prevention (CDC) and the American Thoracic Society (ATS) issued new recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI.) The Start Printed Page 45604CDC's National Center for HIV, STD, and TB Prevention (NCHSTP), Division of Tuberculosis Elimination (DTBE) proposes to collect data to identify potential barriers to the acceptance, implementation, and adherence to targeted testing and treatment of LTBI guidelines.
The specific purpose of this research is:
A. Identify barriers to acceptance, implementation, and adherence to the new targeted testing and treatment of LTBI recommendations.
B. Identify possible education and communication messages, materials, and behavior change strategies to overcome those barriers.
C. Identify acceptable dissemination and media channels.
Approximately, one hundred key-informant telephone interviews with physicians who evaluate tuberculin skin test results and make treatment decisions for individuals with LTBI will be conducted. The target group will include physicians who work in the private sector and public sector in urban and rural areas from throughout the United States.
The total cost to the Federal government is estimated at $50,000, which includes contract staff and respondent incentives. Key informant respondents will receive an incentive of approximately $100 to participate in the telephone interview. Using an estimated cost of $100 per hour, approximately 100 physicians will participate as interview respondents; it is estimated their burden will be one hour and their cost burden will be $100 (per respondent.) The total estimated cost to all respondents is $10,000. The total burden hours are estimated to be 100.
|Respondents||Number of respondents||Number of responses/respondent||Average burden/response (in hours)||Total burden (in hours)|
Dated: July 18, 2000.
Acting Associate Director for Policy, Planning, and Evaluation Centers for Disease Control and Prevention (CDC).
[FR Doc. 00-18660 Filed 7-21-00; 8:45 am]
BILLING CODE 4163-18-P